Green Valley Investors LLC decreased its position in shares of Danaher Corporation (NYSE:DHR) by 3.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 1,232,382 shares of the conglomerate’s stock after selling 48,446 shares during the period. Danaher Corporation accounts for approximately 5.1% of Green Valley Investors LLC’s portfolio, making the stock its 7th largest holding. Green Valley Investors LLC owned approximately 0.18% of Danaher Corporation worth $104,001,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in DHR. BlackRock Inc. lifted its stake in shares of Danaher Corporation by 2,530.9% during the first quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after buying an additional 36,524,795 shares during the period. Flossbach Von Storch AG lifted its stake in shares of Danaher Corporation by 44.7% during the second quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after buying an additional 1,785,810 shares during the period. Vanguard Group Inc. lifted its stake in shares of Danaher Corporation by 3.9% during the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after buying an additional 1,530,015 shares during the period. MARSHALL WACE ASIA Ltd purchased a new position in shares of Danaher Corporation during the first quarter valued at approximately $116,462,000. Finally, Marshall Wace North America L.P. purchased a new position in shares of Danaher Corporation during the first quarter valued at approximately $116,462,000. 75.66% of the stock is currently owned by institutional investors and hedge funds.

In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares in the company, valued at $12,718,425.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The disclosure for this sale can be found here. Insiders sold 71,496 shares of company stock valued at $5,916,223 over the last quarter. Corporate insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/10/16/green-valley-investors-llc-sells-48446-shares-of-danaher-corporation-dhr.html.

Shares of Danaher Corporation (DHR) opened at 86.84 on Monday. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.62. The firm has a market cap of $60.33 billion, a price-to-earnings ratio of 27.72 and a beta of 1.03. The stock has a 50 day moving average of $85.95 and a 200 day moving average of $84.19.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.90 earnings per share. Equities analysts predict that Danaher Corporation will post $3.96 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.

Several brokerages recently issued reports on DHR. Morgan Stanley reissued an “overweight” rating and set a $95.00 price objective (up previously from $86.00) on shares of Danaher Corporation in a research note on Friday, October 6th. Wells Fargo & Company started coverage on shares of Danaher Corporation in a research report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price target for the company. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a research report on Tuesday, September 26th. Cowen and Company reaffirmed a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a research report on Wednesday, October 4th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $92.62.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.